Workflow
Mingyue Optical Lens(301101)
icon
Search documents
明月镜片(301101) - 明月镜片调研活动信息
2022-10-31 04:31
明月镜片股份有限公司 投资者关系活动记录表 编号:2022-005 | --- | --- | --- | |----------------------------------|--------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...
明月镜片(301101) - 2022 Q3 - 季度财报
2022-10-25 16:00
Financial Performance - The company's revenue for Q3 2022 reached ¥168,339,458.13, representing a 21.93% increase year-over-year[7] - Net profit attributable to shareholders was ¥34,993,260.93, a significant increase of 70.47% compared to the same period last year[7] - The net profit after deducting non-recurring gains and losses was ¥27,069,077.41, up 37.54% year-over-year[7] - The basic earnings per share (EPS) was ¥0.2605, reflecting a 5.67% increase from the previous year[7] - Total operating revenue for the current period reached ¥454,730,098.62, an increase of 10.9% compared to ¥409,921,565.38 in the previous period[26] - Net profit for the current period was ¥95,700,799.15, representing a significant increase of 55.8% from ¥61,369,924.24 in the previous period[28] - Basic earnings per share for the current period were ¥0.6493, up from ¥0.5425, marking an increase of 19.7%[30] - The total comprehensive income attributable to shareholders of the parent company was ¥87,226,117.54, compared to ¥54,659,998.83, representing an increase of 59.5%[31] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,593,860,087.39, a slight decrease of 0.10% from the end of the previous year[7] - The total liabilities amounted to ¥134,304,015.16, a decrease from ¥150,229,055.47, indicating a reduction of 10.6%[26] - The total current assets are reported at ¥1,357,796,349.65, slightly down from ¥1,379,001,393.14[22] - The total non-current assets are reported at ¥236,063,737.74, an increase from ¥216,386,289.80[22] - The total equity attributable to shareholders increased by 1.14% to ¥1,420,376,915.27 compared to the end of the previous year[7] - The total equity attributable to shareholders of the parent company was ¥1,420,376,915.27, up from ¥1,404,351,739.73, reflecting a growth of 1.1%[26] Cash Flow - Cash flow from operating activities for the year-to-date was ¥90,233,402.40, an increase of 45.59% compared to the same period last year[7] - Cash flow from operating activities was ¥488,026,196.88, slightly down from ¥491,577,574.51 in the previous period[32] - Net cash flow from operating activities was $90,233,402.40, an increase of 45.5% compared to $61,979,621.13 in the previous period[35] - The company's cash and cash equivalents as of September 30, 2022, amount to ¥124,804,395.03, a decrease from ¥996,794,366.01 at the beginning of the year[20] - Cash flow from investing activities was negative at -¥867,326,869.66, primarily due to investments in financial products[15] - Cash outflow for investment activities amounted to $2,483,845,443.48, compared to $410,825,957.18 in the previous period, resulting in a net cash flow from investment activities of -$867,326,869.66[35] - Cash flow from financing activities showed a net outflow of -$96,440,642.66, compared to -$8,622,852.37 in the previous period[35] Shareholder Information - The total number of common shareholders at the end of the reporting period is 7,187[16] - The largest shareholder, Shanghai Mingyue Industrial Co., Ltd., holds 55.09% of the shares, totaling 74,003,000 shares[16] - The company has a total of 0 preferred shareholders at the end of the reporting period[16] Investment and Expenses - The company reported a significant increase in investment income of 547.66%, amounting to ¥7,767,505.32 for the year-to-date[12] - The company experienced a 726.15% decrease in financial expenses, resulting in a net income of -¥1,531,701.82[12] - Research and development expenses increased to ¥15,094,476.82, compared to ¥13,328,654.15, indicating a growth of 13.3%[28] - Cash received from investment income was $14,066,149.60, up from $1,199,321.11 in the previous period[35] - Cash paid for purchasing goods and services was $199,007,097.49, slightly down from $201,840,974.10 in the previous period[35] - Cash paid to employees was $105,657,896.40, down from $110,820,412.69 in the previous period[35] - Cash paid for taxes increased to $44,419,372.25 from $36,973,540.74 in the previous period[35] Other Information - The company has not disclosed any new strategies or product developments in the current report[18] - Accounts receivable increased to ¥131,287,563.67 from ¥109,645,761.22[20] - Inventory stands at ¥110,273,011.10, up from ¥109,586,517.16[22]
明月镜片(301101) - 2022 Q2 - 季度财报
2022-08-17 16:00
Financial Performance - The company's operating revenue for the first half of 2022 was ¥286,390,640.49, representing a 5.34% increase compared to ¥271,860,173.97 in the same period last year[30]. - Net profit attributable to shareholders of the listed company reached ¥52,236,561.21, a significant increase of 53.05% from ¥34,131,233.91 in the previous year[30]. - The net profit after deducting non-recurring gains and losses was ¥38,819,244.58, which is a 15.37% increase from ¥33,646,925.54 in the same period last year[30]. - The net cash flow from operating activities was ¥60,956,040.83, up 21.86% from ¥50,020,264.23 in the previous year[30]. - Basic earnings per share increased to ¥0.3888, reflecting a 14.76% rise from ¥0.3388 in the same period last year[30]. - Total assets at the end of the reporting period were ¥1,561,258,956.94, a decrease of 2.14% from ¥1,595,387,682.94 at the end of the previous year[30]. - Net assets attributable to shareholders of the listed company were ¥1,385,385,912.09, down 1.35% from ¥1,404,351,739.73 at the end of the previous year[30]. - The weighted average return on net assets was 3.68%, a decrease of 2.59% compared to 6.27% in the previous year[30]. Investment and Funding - The total investment during the reporting period reached approximately CNY 1.60 billion, marking an increase of 813.71% compared to the same period last year[72]. - The total amount of raised funds accumulated is RMB 7,237.75 million[78]. - The total amount of raised funds used for investment projects is RMB 537.75 million, representing 1.79% of the committed investment projects[79]. - The company has permanently supplemented working capital with RMB 6,700 million of the excess raised funds, accounting for 29.78% of the total excess funds[83]. - The total amount of excess raised funds is RMB 22,496.35 million, with no changes in the investment projects[83]. - The company has not changed the use of raised funds, with a total of RMB 73,566.09 million remaining in the special account for future investment[86]. - The company has invested RMB 28,800 million in bank wealth management products from its own funds and RMB 69,800 million from raised funds[89]. - The total amount of entrusted wealth management is RMB 98,600 million, with no overdue amounts[89]. Product Development and Market Strategy - The company has established a global leading lens material R&D and production center in collaboration with Mitsui from Japan and KOC from South Korea, achieving self-sufficiency in lens materials[40]. - The "Easy Control" series of products, designed for children, includes four SKUs and has shown significant effectiveness in controlling rapid axial growth and delaying myopia progression[41]. - The company plans to develop direct sales, distribution, and medical channels in a coordinated manner to enhance market penetration[41]. - The company has permanently exited the price war and is systematically withdrawing from the excessively competitive low-end market[41]. - The company has a comprehensive range of functional lenses that meet various consumer needs, including myopia management and anti-blue light features[42]. - The company has established a dedicated department to develop large and chain medical channels, leveraging partnerships to accelerate market entry[41]. - The company reported a direct sales revenue of 186.16 million yuan, accounting for 65.00% of total revenue, while distribution channel revenue was 75.33 million yuan, making up 26.30% of total revenue[50]. - The company has developed the "Easy Control" and "Easy Control Pro" lenses, which utilize advanced technologies such as asymmetrical design and light tracking, enhancing comfort and wearability for children[47]. - The lenses have a refractive index range of 1.60 to 1.71, significantly higher than the 1.59 of competing products, providing better optical parameters and lighter weight[49]. - The company has established a strong brand presence in the domestic market, with a stable customer base of 2,924 direct sales clients and 33 distribution clients as of June 30, 2022[50]. - The company holds 142 patents, including 14 invention patents, indicating a strong technological advantage in lens production and design[54]. - The company launched eight SKUs in the myopia management lens category, maintaining a leading position in product line richness[55]. - The company has actively engaged in brand-building activities, including partnerships with high-profile events and media, enhancing brand recognition and market influence[51]. - The company’s products have been used in significant national projects, including the Everest height measurement and the Shenzhou XII mission, showcasing their quality and reliability[56]. - The company is focusing on high-refractive index and functional lenses, which are expected to drive substantial growth in the future[56]. - The company has integrated online and offline sales channels, enhancing consumer access to its products through platforms like Tmall and JD[51]. Environmental Compliance and Sustainability - The company reported a total emission of 0.014 tons of particulate matter, which is compliant with the standard[115]. - The volatile organic compounds (VOCs) emissions totaled 0.111 tons, also meeting the required standards[115]. - Chemical oxygen demand (COD) emissions were recorded at 8.35 tons, with a maximum allowable limit of 16.64 tons per year[115]. - The company has implemented a self-monitoring plan for emissions, with no exceedances reported in the monitoring results[120]. - The company has established a stable operation of pollution control facilities, ensuring all emissions are within the regulatory limits[120]. - The company has engaged qualified third parties for the disposal of hazardous waste generated during production[120]. - The company is committed to complying with environmental regulations and has successfully implemented pollution prevention measures[120]. - The company emphasizes energy conservation and sustainable development, implementing measures to reduce carbon emissions and improve production efficiency[127]. Corporate Governance and Compliance - The company has not faced any administrative penalties related to environmental issues during the reporting period[127]. - The company fulfilled all commitments related to the initial public offering and refinancing during the reporting period[138]. - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[139]. - The company reported no significant litigation or arbitration matters during the reporting period[144]. - The company had no significant related party transactions during the reporting period, with a total related party transaction amount of 356,000 RMB[147]. - There were no asset or equity acquisitions or sales during the reporting period[148]. - The company did not engage in any joint external investment transactions during the reporting period[151]. - The company reported no significant guarantees during the reporting period[156]. - There were no major contracts or significant risks affecting contract performance during the reporting period[160]. - The company did not experience any major events that required explanation during the reporting period[162]. - The company reported no significant changes in shareholder structure during the reporting period[165]. Shareholder Information - The total number of shares before the change was 134,341,400, with a total of 1,650,629 shares reduced, resulting in 103,059,232 shares after the change, representing 76.71% of the total[167]. - The number of unlimited sale condition shares increased from 29,631,539 to 31,282,168, which is a growth of 1,650,629 shares, representing 23.29% of the total[171]. - The largest shareholder, Shanghai Mingyue Industrial Co., Ltd., holds 74,003,000 shares, accounting for 55.09% of the total shares[175]. - The company has a total of 11,843 shareholders, with 10 shareholders holding more than 5% of the ordinary shares[175]. - The strategic placement plan by CITIC Securities allocated 2,303,232 shares, which is 6.86% of the total issuance[178]. - The total number of limited sale condition shares decreased from 104,709,861 to 103,059,232, indicating a reduction of 1,650,629 shares[174]. - The proportion of domestic legal person holdings decreased from 68.80% to 67.59% after the share reduction[171]. - The foreign shareholding decreased to 0, with a reduction of 10,049 shares[171]. - The number of domestic natural person holdings slightly decreased from 12,263,523 to 12,257,000, a reduction of 6,523 shares[171]. - The company plans to lift the lock-up period for certain shareholders on December 15, 2024, for a total of 74,003,000 shares[171]. Liquidity and Financial Position - As of June 30, 2022, the company's total assets amounted to approximately CNY 1,561.26 million, a decrease from CNY 1,595.39 million at the beginning of the year[196]. - The company's cash and cash equivalents decreased to CNY 113.57 million from CNY 996.79 million at the beginning of the year, indicating a significant reduction in liquidity[196]. - The company's accounts receivable increased to CNY 127.30 million from CNY 109.65 million, reflecting a growth of approximately 16%[196]. - The company's inventory stood at CNY 110.71 million, slightly up from CNY 109.59 million, showing a marginal increase[196]. - Non-current assets totaled CNY 223.67 million, up from CNY 216.39 million, indicating a growth of about 3%[199]. - The company's short-term borrowings were not reported, suggesting no reliance on short-term debt financing during the period[199]. - Accounts payable decreased to CNY 57.05 million from CNY 68.14 million, representing a decline of approximately 16%[199]. - The company reported a decrease in other payables to CNY 25.61 million from CNY 33.11 million, indicating a reduction of about 23%[199].
明月镜片(301101) - 2022 Q1 - 季度财报
2022-04-24 16:00
Financial Performance - The company's operating revenue for Q1 2022 was CNY 136,199,535.62, representing a 13.26% increase compared to CNY 120,251,902.03 in the same period last year[4] - Net profit attributable to shareholders was CNY 22,113,773.37, a significant increase of 70.01% from CNY 13,007,547.68 year-on-year[4] - The total profit for the period was CNY 28,742,011.60, reflecting a 56.47% increase from CNY 18,369,007.82 in the previous year[10] - The company reported a net profit margin of 17.99% for the quarter, up from 10.81% in the same period last year, indicating improved profitability[10] - Net profit for the period was ¥24,310,903.39, representing a significant increase of 57.7% from ¥15,408,171.17 in the same quarter last year[30] Earnings and Shareholder Information - Basic earnings per share rose to CNY 0.1646, reflecting a 27.50% increase from CNY 0.1291 in the same quarter last year[4] - Earnings per share (EPS) for the quarter was ¥0.1646, compared to ¥0.1291 in the previous year, indicating a growth of 27.3%[32] - The total number of common shareholders at the end of the reporting period is 18,528, with the largest shareholder, Shanghai Mingyue Industrial Co., holding 55.09% of shares[11] - The company has a total of 74,003,000 shares held by the largest shareholder, Shanghai Mingyue Industrial Co.[11] - The company has a total of 2,340,000 shares held by Dan Yang Zhiming Enterprise Management Center (Limited Partnership)[14] Cash Flow and Investments - The net cash flow from operating activities surged to CNY 9,387,448.32, marking an increase of 1,892.56% compared to CNY 471,125.14 in the previous year[4] - Total cash inflow from operating activities is ¥144,413,467.29, slightly down from ¥146,841,421.65 in the previous period[34] - Cash outflow from operating activities totals ¥135,026,018.97, compared to ¥146,370,296.51 in the previous period[37] - Cash inflow from investment activities is ¥30,016,437.80, up from ¥25,152,047.38 in the previous period[37] - The net cash flow from investment activities is -¥798,229,734.19, worsening from -¥91,217,650.87 in the previous period[37] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,590,760,668.70, a slight decrease of 0.29% from CNY 1,595,387,682.94 at the end of the previous year[4] - The total assets of the company were reported at ¥1,590,760,668.70, slightly down from ¥1,595,387,682.94[29] - The total liabilities decreased to ¥127,088,040.06 from ¥150,229,055.47, a reduction of approximately 15.4%[24] - The company's accounts payable decreased to ¥49,778,048.53 from ¥68,144,571.74[21] - The company's cash and cash equivalents amounted to ¥191,232,993.52, a decrease from ¥996,794,366.01 at the beginning of the year[18] Expenses - Total operating costs amounted to ¥112,823,629.98, up from ¥103,340,417.38, reflecting a year-over-year increase of 9.4%[27] - Research and development expenses for the quarter were ¥4,135,120.23, up from ¥3,926,804.78, reflecting a year-over-year increase of 5.3%[30] - The company reported a decrease in sales expenses to ¥24,892,178.15 from ¥26,890,289.65, a decline of 7.4%[30] - The company experienced a 121.24% increase in taxes payable, amounting to CNY 13,184,944.33, attributed to increased VAT and corporate income tax[7] Other Financial Metrics - The company's weighted average return on equity was 1.56%, down by 0.88% from 2.44% in the same period last year[4] - Other comprehensive income after tax was reported at -¥989.12, compared to ¥574.57 in the previous year, indicating a negative shift[32] - The company's retained earnings increased to ¥240,710,515.59 from ¥218,596,742.22, showing a growth of 10.4%[24] - The company has a total of 3,818,067.14 in right-of-use assets, down from 4,939,116.41[21]
明月镜片(301101) - 2021 Q4 - 年度财报
2022-04-24 16:00
Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, representing a year-on-year growth of 15%[20] - The net profit for 2021 was RMB 300 million, an increase of 20% compared to the previous year[20] - The company's operating revenue for 2021 was ¥575,569,283.16, representing a 6.65% increase from ¥539,681,448.04 in 2020[26] - The net profit attributable to shareholders for 2021 was ¥82,094,094.80, a 17.27% increase from ¥70,004,861.36 in 2020[26] - The net cash flow from operating activities increased by 56.85% to ¥142,937,317.77 in 2021 from ¥91,130,927.15 in 2020[26] - The total assets at the end of 2021 were ¥1,595,387,682.94, a 130.62% increase compared to ¥691,775,768.68 at the end of 2020[26] - The net assets attributable to shareholders at the end of 2021 were ¥1,404,351,739.73, reflecting a 166.41% increase from ¥527,142,893.40 at the end of 2020[26] - The basic earnings per share for 2021 was ¥0.8148, up 17.27% from ¥0.6948 in 2020[26] Market Expansion and Strategy - The company is focusing on expanding its market presence in Southeast Asia, targeting a 10% market share by 2023[20] - Future guidance estimates a revenue growth of 12% to 15% for 2022, driven by new product launches and market expansion efforts[20] - The company has maintained a leading position in the Chinese optical lens market, being recognized as the top seller in retail volume from 2016 to 2020 according to Euromonitor International[43] - The company aims to enhance brand awareness and expand its marketing network, including opening experience stores in major cities[124] - The company plans to focus on functional lens products, with new product launches expected to drive market growth[125] Product Development and Innovation - New product development includes the launch of a high-definition lens series, expected to contribute an additional RMB 100 million in revenue in 2022[20] - The company has allocated RMB 50 million for research and development in new optical technologies for the upcoming year[20] - The company has partnered with renowned optical experts to establish an industry-leading research and development center, enhancing its competitive edge in optical design and lens coating technologies[43] - The company launched the "Easy Control" (refractive index 1.60) and "Easy Control Pro" (refractive index 1.67) lenses specifically designed for children, utilizing advanced technologies to effectively slow down the progression of myopia[48] - The company launched the second generation of its youth myopia management lens product "Easy Control Pro" in December 2021, expanding its market presence[59] Financial Management and Investments - The total investment during the reporting period was ¥630,800,000.00, a 357.10% increase compared to the previous year's investment of ¥138,000,000.00[97] - The company reported an investment income of ¥2,837,638.84, accounting for 2.64% of total profit, primarily from financial product returns[87] - The company's accounts receivable decreased by 11.70% year-on-year to ¥109,645,761.22, indicating improved cash flow management[88] - The company's inventory increased by 7.74% year-on-year to ¥109,586,517.16, reflecting ongoing operational needs[88] - The company has committed a total of RMB 56,796.04 million for various projects, including high-end resin lens expansion and R&D center construction, with no funds utilized yet[104] Risk Management - The company has identified key risk factors in its operational environment, advising investors to remain cautious[7] - The company faces risks from macroeconomic conditions that could negatively impact demand for its lens products if disposable income growth slows[132] - The company has a risk of not achieving expected returns from its fundraising investment projects due to market changes affecting sales prices and production costs[136] Corporate Governance - The company maintains a governance structure that complies with relevant laws and regulations, ensuring transparency and accountability in its operations[141] - The company has established an independent financial department with a complete financial accounting system, ensuring independent financial decision-making and compliance with tax obligations[154] - The company has a well-structured internal management system, with 100% participation in the annual and temporary shareholder meetings held in 2021[157] - The company has no related party transactions that are significantly unfair, maintaining a fair business environment[156] Employee Management and Development - The total number of employees at the end of the reporting period was 1,196, with 749 in the parent company and 447 in major subsidiaries[189] - The company has implemented a competitive salary system in collaboration with a leading human resources firm, focusing on performance-based incentives[193] - The training program covers all levels and positions, enhancing employees' core competencies and business knowledge[194] - The company is committed to improving talent development and retention through a scientific compensation and assessment system[130] Dividend Distribution - The company plans to distribute a cash dividend of RMB 5.3 per 10 shares, totaling RMB 71,200,942 (including tax) based on a total share capital of 134,341,400 shares[197] - The cash dividend represents 100% of the total distributable profit of RMB 126,667,801.34[198] - No stock dividends or share repurchases are included in the profit distribution plan[198]